Pharmaceutical

Kenox and Lactiga partner on sIgA therapies for immunodeficiency

Kenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.

Mar 11, 2025 - 06:00
Kenox and Lactiga partner on sIgA therapies for immunodeficiency
Kenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.
Read the original article

Tags:

Previous Article

Exploring New Avenues in Disease Treatment: Traditional Chinese Medicine’s Role ...

Next Article

AstraZeneca and Ionis win EU approval for ATTR polyneuropathy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Bavarian Nordic outlays 215,000 mpox vaccine dose supply to African countries

Bavarian Nordic outlays 215,000 mpox vaccine dose suppl...

Aug 15, 2024

STAT+: Pharmalittle: FDA finds ‘potential systemic bias’ in Amgen cancer drug trial; drugmakers organize to push back on antitrust reviews

STAT+: Pharmalittle: FDA finds ‘potential systemic bias...

Oct 4, 2023

Prodrugs and patents: Enhancing therapy adherence and reducing side effects 

Prodrugs and patents: Enhancing therapy adherence and r...

Sep 12, 2024